ANAB

Anaptysbio Inc

Don't Wait for the Ginkgo Bioworks IPO to Profit from This $3 Billion Industry

November 1, 2017 by Jack Delaney

After making Forbes list for the next billion-dollar startup, anxious investors are hoping a Ginkgo Bioworks IPO is in the works.

That's because biotech and healthcare IPOs are netting investors gains as much as 300% so far in 2017.

Here are all the details about Ginkgo, as well as a special profit opportunity forming in the $3 trillion healthcare industry...

IPO News: Is This Extremely Secretive $4.7 Billion Company About to Go Public?

March 31, 2017 by Jack Delaney

In recent IPO news, Wall Street is buzzing about a secretive company that could go public.

This biotech firm is valued by some at $4.7 billion, despite not having any products on the market.

And because of a lawsuit, we know more about this company than ever before. This could be one of the biggest healthcare IPOs of 2017...